Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Collegium Pharmaceutical Inc

COLL
Current price
25.6 USD -0.03 USD (-0.12%)
Last closed 25.63 USD
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 849 187 840 USD
Yield for 12 month +11.21 %
Week
Month
Year
COLL
21.11.2021 - 28.11.2021

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts. Address: 100 Technology Center Drive, Stoughton, MA, United States, 02072

Analytics

WallStreet Target Price

33.5 USD

P/E ratio

108.5

Dividend Yield

Current Year

+463 933 000 USD

Last Year

+276 868 000 USD

Current Quarter

+136 709 000 USD

Last Quarter

+135 546 000 USD

Current Year

+209 488 000 USD

Last Year

+150 617 000 USD

Current Quarter

+80 311 000 USD

Last Quarter

+73 826 000 USD

Key Figures COLL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 242 574 000 USD
Operating Margin TTM 33.07 %
PE Ratio 108.5
Return On Assets TTM 4.5 %
PEG Ratio
Return On Equity TTM 4.8 %
Wall Street Target Price 33.5 USD
Revenue TTM 546 641 984 USD
Book Value 5.41 USD
Revenue Per Share TTM 16.05 USD
Dividend Share
Quarterly Revenue Growth YOY 7.6 %
Dividend Yield
Gross Profit TTM 345 743 000 USD
Earnings Share 0.24 USD
Diluted Eps TTM 0.24 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY 5197.6 %
Profit Margin 1.65 %

Dividend Analytics COLL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History COLL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation COLL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 108.5
Forward PE 4.4444
Enterprise Value Revenue 3.7576
Price Sales TTM 2.0913
Enterprise Value EBITDA 13.5205
Price Book MRQ 3.8595

Financials COLL

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators COLL

For 52 weeks

20.83 USD 30.22 USD
50 Day MA 22.95 USD
Shares Short Prior Month 6 482 154
200 Day MA 23.3 USD
Short Ratio 22.92
Shares Short 6 013 088
Short Percent 22.62 %